Allergic sensitization: food- and protein-related factors by Scott McClain et al.
McClain et al. Clinical and Translational Allergy 2014, 4:11
http://www.ctajournal.com/content/4/1/11REVIEW Open AccessAllergic sensitization: food- and protein-related
factors
Scott McClain1*, Christal Bowman2, Montserrat Fernández-Rivas3, Gregory S Ladics4 and Ronald van Ree5Abstract
Presented here are emerging capabilities to precisely measure endogenous allergens in soybean and maize,
consideration of food matrices on allergens, and proteolytic activity of allergens. Also examined are observations of
global allergy surveys and the prevalence of food allergy across different locales. Allergenic potential is considered
in the context of how allergens can be characterized for their biochemical features and the potential for proteins to
initiate a specific immune response. Some of the limitations in performing allergen characterization studies are
examined. A combination of physical traits of proteins, the molecular interaction between cells and proteins in the
human body, and the uniqueness of human culture play a role in understanding and eventually predicting protein
allergy potential. The impact of measuring food allergens on determining safety for novel food crops and existing
allergenic foods was highlighted with the conclusion that measuring content without the context of clinically
relevant thresholds adds little value to safety. These data and findings were presented at a 2012 international
symposium in Prague organized by the Protein Allergenicity Technical Committee of the International Life Sciences
Institute’s Health and Environmental Sciences Institute.
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In April 2012, an international symposium titled “Sensitizing
Properties of Proteins” was held in Prague, Czech Republic,
bringing together over 70 scientists from academia, gov-
ernment, and industry. The purpose of the symposium,
organized by the Protein Allergenicity Technical Committee
(PATC) of the International Life Sciences Institute’s
(ILSI) Health and Environmental Sciences Institute
(HESI), was to present data on the current state of the
science regarding the sensitizing properties of proteins
in relation to food allergy [1-3]. Food- and protein-
related factors are the focus of this paper.
Assessing sensitization potential is difficult to address
because defining the characterization parameters that
could be applied in a “safety testing platform” for food
allergy risk have not yet been completed. Summarized
here are some of the biophysical features of protein al-
lergens, how and why allergen content is measured, and
the way in which allergens interact with the immune* Correspondence: scott.mcclain@syngenta.com
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unless otherwise stated.system at the molecular level as well as at the human
population level. Topics include 1) prevalence of known
food allergens from a global perspective, 2) understand-
ing endogenous protein allergenicity in the context of
new foods and particularly genetically modified (GM)
food crops, 3) food matrix effects on allergenic potential
of proteins, and 4) proteolytic effects of allergens on
sensitization potential.Prevalence of allergies around the globe
Tracking the prevalence of food allergy is considered crit-
ical to understanding how different populations become
sensitized to allergens and where clinically relevant allergy
emerges and persists. Characterizing geographically
distinct allergens can help clarify the overall allergy
disease process, which will someday help provide a path
to predicting when, where and how allergy develops in
individuals as well as populations. Understanding ex-
posure and sensitization in distinct populations there-
fore has touchstones in characterizing not only known
allergens, but charactering novel food proteins whether
they arise from newly introduced foods or novel
biotechnology. Although a mechanistic approach tol Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cellular level is necessary, prevalence is a bellwether that
can alert scientists to regional or global changes. More
than 150 foods have been implicated in allergic reactions,
but the majority are induced by a small number of foods.
In 1995, a Food and Agriculture Organization (FAO) tech-
nical consultation identified the following eight food
groups as the most common causes of allergy worldwide:
milk, egg, peanut, tree nuts, wheat, soy, fish and shellfish.
These foods are known since then as the “the big eight
allergens”, and are recognized as allergenic foods of public
health importance. Therefore, they are included in regula-
tory allergen lists worldwide. Recent studies on prevalence
are helping to support a broader inclusion of foods on the
list of prominent allergenic foods, particularly in Europe,
and some countries survey newly imported foods for aller-
genic potential. However, the 1995 FAO list of eight re-
mains a foundation of how food allergens are prioritized.
The main criterion for inclusion in the big eight aller-
gen list was the frequency of reported reactions. There
are, however, some drawbacks to worldwide application
of this list. First, epidemiological studies in food allergy
in 1995 were limited, and even today, more than 85% of
them have been performed in Europe, the United States
(US), Canada, Australia and New Zealand. There are a
few surveys carried out in Asia, and there is very scarce
information about food allergy in Africa and Latin
America. Second, recent meta-analysis and large scale
reviews of food allergy epidemiology [4,5] have raised
major issues about the comparability of studies due to
marked heterogeneity in the design, the instruments
applied, and selection of outcome measurements. De-
pending on the “definition” of food allergy, the overall
estimate of prevalence changes with a progressive re-
duction: self-reported reactions > IgE sensitization >
combination of symptoms and IgE sensitization > oral
food challenges.
Milk and egg allergies are the most prevalent world-
wide in children below four years of age. The preva-
lence based on food challenge studies has varied from
0% to 3% for milk, and from 0% to 9% for egg. Because
tolerance develops spontaneously in the majority of
patients (more commonly to milk), the prevalence is re-
duced in schoolchildren and adolescents, and milk and
egg allergies reported in Australia are very uncommon
in adults [4,6,7].
Peanut allergy is highly prevalent in the US, Canada,
Australia and the United Kingdom (UK). It starts early
in childhood with figures of 2.9% in one-year-old infants
from Australia, affects around 1.5% of school age chil-
dren and adolescents, and occurs in 0.7% of adults
[4,6,7]. A lower incidence has been observed in Asia and
Israel. In Japan, peanut induces only 2% of all food aller-
gic reactions [8]. A survey carried out in schoolchildrenin Singapore and the Philippines found a prevalence of
peanut allergy of 0.43% to 0.67% among children of
Asian origin, whereas in (western born) expatriate chil-
dren it was 1.2% [9]. Similarly, the prevalence of peanut
allergy in Jewish children in Israel was 0.17%, whereas
that of Jewish children in the UK was 1.85% [4,7]. Inter-
estingly, the prevalence of milk allergy in Israel was also
lower, i.e., 0.5% in children 3–5 years of age, which con-
trasts with figures of 1.8%-2.9% in children of the same
age in the US and UK [4,7].
The prevalence of tree nut allergy as confirmed by oral
challenge has ranged from 0.1% (almond in the UK) to
4.3% (hazelnut in adolescents 15–17 years of age in
Germany) [5]. The prevalence in the US and Canada using
a random telephone survey was 0.5% and 1% in adults, and
1.1% and 1.6% in children, respectively [7]. Similar to obser-
vations recorded for peanut, the prevalence of tree nut al-
lergy in Asian children from Singapore and the Philippines
was 0.3%, whereas in expatriate children it was 1.2% [9].
According to European studies, the prevalence of aller-
gies to wheat and soy that included identification by oral
challenges was 0%-0.5% and 0%-0.7%, respectively. How-
ever, serum-specific IgE to wheat was found in 3.6% of
adults and to soy in 2.1%-2.9% of adults [5]. This dis-
crepancy may reflect the presence of cross-reactive IgE
antibodies with grass and birch pollen in patients with-
out clinically relevant food allergy to soy or wheat being
the main culprit.
In contrast to Western countries, wheat allergy is very
prevalent in Japan, inducing 10% of all immediate reac-
tions to foods, and it was ranked third for inducing aller-
gic reactions after egg (29%) and milk (23%). It is also
noteworthy that buckwheat (a non-cereal grain used in
soba noodles) accounted for 6% of all food allergic
reactions in Japan in one study, although the frequency
doubled in patients older than 7 years [8].
The prevalence of fish allergy in studies carried out in
Scandinavia, the UK, the US, and Canada varied between
0.2% to 0.6% [4,7]. In Japan, 5% of food allergic reactions
were due to fish ingestion [8], demonstrating a substan-
tial difference in prevalence compared to these other
countries. The prevalence of shellfish allergy in studies
performed in Europe and the US that combine symp-
toms and IgE sensitization was 0.6% in a study by Rona
et al. [4]. In random telephone surveys performed in the
US and Canada, the prevalence of shellfish allergy in
adults was 2.5% and 1.7%, respectively, whereas in
Canadian children the estimate was 0.5% [7]. In Asian
countries, the overall prevalence of shellfish allergy
was higher, and it is the most important food allergy in
school age children, adolescents and adults [8,9]. In
Singapore and the Philippines, the prevalence of shell-
fish allergy in schoolchildren of Asian origin was 1.2%
in children 4–6 years of age and rose to 5.2% in those
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same age groups in western-born expatriates was
0.55% and 0.96%, respectively [9].
Allergy to fruits and vegetables has been primarily
investigated in Europe with scarce information available
from other geographic areas. In Europe, the prevalence
of fruit allergy confirmed by oral food challenges varied
from 0.1% to 4.3%. The fruits most commonly involved
are those belonging to the Rosaceae family (e.g., apple,
peach, and cherry) [5,10]. Allergy to vegetables is less
frequent with prevalence in the general population oc-
curring at 0.1% to 1.8% [5,10]. The vegetables most com-
monly involved in allergic reactions are those from the
Apiaceae family (celery and carrot) and tomato [5,10].
One of the main features of allergy to fruits and vegeta-
bles is its frequent association with pollen allergies
(pollen-food syndrome). The allergy progression begins
with a primary sensitization induced by pollen exposure
and the plant allergy appears later as a result of cross-
reactive IgE to allergens found in pollens and foods.
Examples include the Bet v 1 homologues and profilins.
Allergies to tree nuts and peanut can also be linked to
pollen allergy. For this reason plant food allergies are
more frequently found in pollen allergic patients. In a
study performed in Denmark, the prevalence of plant
food allergies in (birch) pollen allergic patients was
19.2% for hazelnut, 16.7% for apple, 13.3% for kiwi, 7.6%
for celery, and 5% for tomato [10].
Recently, within the EuroPrevall project (publication
pending), two epidemiological surveys were carried out
in schoolchildren and adults from the general popula-
tion. In addition, more than 2000 patients from 12
allergy clinics across Europe were fully evaluated. All of
these studies confirmed the importance of plant food al-
lergies in schoolchildren and adults. The most prevalent
food groups were (in decreasing order) fruits, tree nuts,
vegetables, and peanut. Egg and milk were the most
prevalent foods in small children; fish and shellfish were
not common; and wheat and soybean allergies were very
rare (unpublished data).
In summary, the most prevalent food allergies vary
worldwide. As discussed, there can be dramatic differ-
ences regionally in the prevalence to a common food
allergen. With priorities on important allergens being set
by prevalence, different regions would be expected to
have differing “top ten” lists of allergenic foods. There
are important age and geographical differences in the
prevalence of allergy to individual foods that depend on
different dietary habits, environmental factors such as
pollen exposure, and possibly genetics. More research is
needed to fully delineate the global prevalence of food
allergies, but it is expected that the EuroPrevall project
will help shed light on this variable global phenomenon
once all of the data are interpreted and disseminated.Variability of endogenous protein allergen levels in
non-GM crops and their relevance to the safety
assessment of GM crops
Speakers and participants engaged in a discussion about
the relevance and purpose of quantifying endogenous
protein allergen content in GM crops. The safety value
of measuring the content of endogenous protein aller-
gens in various food crops, particularly soybean, arose as
a regulatory concern for GM crops in the last five years.
Recent guidance from the European Food Safety
Authority contains the precipitating language that ties
endogenous allergen considerations to putative unin-
tended GM effects: “with alterations to the allergenicity
of the whole plant and derived products e.g. due to
over-expression of natural endogenous allergens as an
unintended effect of the genetic modification” [11]. The
questions then are: What is the best way to analytically
measure potential increases in allergen content? Can
quantitative measurement of allergen content address
allergenicity risk? The concern over GM crops is about
the potential change in allergen levels due to gene ma-
nipulation and this was addressed at the symposium in
the context of newly developed methods for measuring
allergens.
Presumably, individuals with food allergies could
minimize their symptoms by selecting food varieties with
low allergen content. However, this is not a practical so-
lution because foods are not assessed or labeled for their
quantitative allergen content; rather, if assessed at all,
foods are evaluated only for the putative presence of
allergens. From a patient safety perspective, allergic indi-
viduals will typically avoid offending foods (whether GM
or non-GM derived), thus reducing exposure to any level
of endogenous allergen to a negligible level for any sin-
gle variety (e.g., registered GM variety) of a commodity
crop such as soybean. If a conventional food crop is
known to be allergenic (e.g., soybean) and is already reg-
ulated as such (i.e., via labeling), the question then can
be asked: How important is a change in allergen con-
tent? In contrast to GM varieties, new non-GM soybean
varieties can be and are introduced into the food supply
with no requirement for a pre-market safety assessment
and no required information on whether allergen levels
have been altered. If this were a pertinent question
unique to GM crops, then understanding natural vari-
ability of in vivo allergen content (in seed/grain) would
be important. However, if the recognized inherent vari-
ability in allergen content [12] is not considered a safety
issue for nontransgenic crop varieties, there is no evi-
dence to suggest that a safety concern exists for GM
varieties.
Currently, a robust safety assessment is in place for
GM foods, and is performed according to regulatory rec-
ommendations; a full and thorough accounting of food
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life cycle and includes a proactive approach to steward-
ship. As part of the food safety risk assessment, some
regulatory authorities require an assessment of endogen-
ous allergen levels in certain GM crops (e.g., soybean)
which relies on a comparison to their non-GM counter-
part. This drives towards a definitive yes or no answer as
to whether changes have occurred in endogenous aller-
gen levels despite a lack of knowledge regarding natural
variability in the concentrations of specific allergens.
Quantifying the amount of endogenous allergens in GM
crops is of negligible value in a safety assessment of a
particular crop variety where natural variability is not
well understood, clinical threshold values of exposure
are not established, and the variety itself is always mixed
with other commodity varieties on the open market.
Across non-GM crop cultivars, endogenous allergen
levels have been found to vary considerably due to geno-
type, environmental conditions, harvest timing, and/or
storage conditions. For example, Ariyarathna et al. [13]
reported up to a 15-fold difference in lipid transfer pro-
tein (LTP) levels in non-GM maize hybrids grown in
Nebraska. In addition, most maize hybrids showed an
increased amount of LTP in an un-irrigated location com-
pared to two irrigated locations. Similarly, Kuppannan
et al. [14] quantitatively evaluated LTP levels in 14 com-
mercially available non-GM maize varieties using liquid
chromatography (LC)-ultraviolet/mass spectrometry (MS)
and reported LTP levels to vary between 58 and 678 μg/g
(approximately 12-fold). Allergen levels in 20 varieties of
commercially available non-GM soybean were found to
vary up to 10-fold by quantifying multiple proteins by LC-
MS [12]. Stevenson et al. [15] evaluated the influence of
genotype and environment on allergen and anti-nutritional
proteins in soybean using LC-MS and found that, for most
allergens, the effects of environment were more important
than differences between varieties brought about by breed-
ing. The content of Gly m 4, the Bet v 1 homologue pro-
tein found in soybean, was measured in four non-GM
varieties grown at five different locations in North Amer-
ica, and concentrations (μg/g of protein) were found to
vary from approximately 2–7 fold. Thus, there appears to
be marked variability in the levels of allergenic proteins in
non-GM crops already in the food supply based on variety,
abiotic and biotic stresses, and growing location. Interest-
ingly, a recent literature review found that transgenesis
had less impact on genome expression and concentra-
tions of proteins or metabolites compared with conven-
tional breeding or plant non-directed mutagenesis [16],
highlighting the difficulty in hypothesizing that there is
undue risk in increased protein allergen levels due to
transgenesis.
It is currently not possible to correlate individual pro-
tein allergen concentrations with the risk of eliciting aclinically relevant response in sensitized individuals
(i.e., allergy risk) relative to the exposure to the protein
through food because of the limited availability of data
on quantitative thresholds for sensitized individuals.
This applies to most allergenic foods which include the
important commodity crops such as soybean. Presumably,
future work would focus on using recent advancements in
measuring individual allergens to better understand elic-
ited patient responses in controlled exposure trials. Un-
derstanding individual allergen dose responses would be
critical to establishing threshold exposure levels; yet this is
just one aspect of the complicated nature of allergen
exposure as it pertains to considering how allergens enter
the human body in the context of the constituent food
components in which protein allergens are embedded.
This greater level of consideration for allergen exposure is
discussed in the “matrix effects on allergenicity” section.
An important consideration for GM safety testing is to
ask the question most pertinent for working towards an
answer that can inform safety. Simplistically, the ques-
tion may appear to be, What is the hypothesis that will
support the comparison of the GM versus the non-GM
crop? The premise behind this question appears to be
that greater exposure to a protein(s) by consuming
potentially higher concentrations in foods results in a
higher frequency of sensitization within a population.
This hypothesis, however, is not so straightforward.
Greater exposure at a young age to allergens such as
peanut, hen’s egg, or cow’s milk can have the opposite
result [17,18], whereby increased exposure supports tol-
erance. There also remains a lack of clinically-based rec-
ommendations for safe consumption levels of allergenic
foods and the processed consumables made from these
foods. In addition, any discussion regarding how to ad-
dress endogenous allergen content should observe the
fact that the quantity of food consumed by a given indi-
vidual is not subject to regulation; without this recogni-
tion, there is a limit to the ability to characterize
exposure variability based merely on the concentration
of an allergen in a food and still provide context for GM
safety testing of endogenous allergens.
In summary, measuring precise levels of endogenous
allergens is not warranted for GM food safety assess-
ment purposes for the following reasons:
1) There is a lack of clarity on whether safety of GM
crops is enhanced beyond existing guidance and
actions that support safe GM products in the
marketplace.
2) Interpretation of small concentration differences for
allergens is problematic because information on
exposure levels and sensitization thresholds is
lacking for individual allergens. Crops such as
soybean contain many individual allergen proteins.
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from measuring individual allergens (particularly in
complex foods with multiple allergens), irrespective
of improvements in the sensitivity of analytical
detection.
4) It is impractical to distinguish between GM and
conventional crop varieties in terms of clinically
relevant endogenous allergenicity.
Until exposure thresholds to individual allergens are
identified, there is no defined degree of added value to
the safety testing of GM crops or any other allergenic
food by quantitatively measuring allergens.
Matrix effects on allergenicity
Foods consist of a complex mixture of substances col-
lectively known as a food matrix. The matrix becomes
an important factor in understanding sensitization to
specific protein allergens because the allergen is never in
initial contact with the immune system in a purified
state; the matrix surrounds, interacts with, and can affect
the physiochemical features of the allergens. Matrix
components constitute the milieu of proteins, carbohy-
drates, phytochemicals, etc., from various parts of a
plant or organism which may interact with an allergen
of interest. Although a list of putative matrix compo-
nents in plants alone is virtually endless, the study of
food allergens has mainly centered around interactions
with components in most abundance in the most com-
monly consumed foods. Matrices can be particularly im-
portant during the processing of foods where proteins
can be exposed to pH changes, heat, and other environ-
mental changes. Multiple guidance and consensus docu-
ments for assessing potential allergenicity cite the need
to consider the effects of the food matrix. However, in-
formation regarding the role of the matrix in allergen-
icity is scarce. In contrast to analytically measuring
allergens, there are no straightforward approaches to ad-
dressing the many variables represented by the matrix
components in foods. As discussed, soybean is the pri-
mary focus of GM endogenous allergen considerations;
yet there are no prescriptive approaches to quantitatively
consider the impact of matrices, if indeed endogenous
allergen hazards were identified. In this context, this is
largely a discussion on the evolving science of the bio-
availability of food allergens to the immune system.
Currently, the primary influences of the matrix on
allergenicity are thought to be antigen bioavailability and
release, digestibility, and interactions with the immune
system. The matrix surrounding a protein of interest
may contain other proteins, fats, carbohydrates, and nu-
merous non-nutritive components with unknown poten-
tial for influencing allergenicity. Lipids can influence
sensitization and the severity of elicitation responses viaaltered antigen release, digestion or immunomodula-
tion. Matrix sugar content can alter digestion and im-
pact the modification of allergens during processing,
thus enhancing or diminishing allergenicity. Protein-
protein interactions may also impact allergen digestion,
and matrix proteins have the potential to directly
stimulate the immune system. Additionally, most foods
contain low levels of non-nutritive substances and con-
taminants, some of which may be immunomodulatory.
Antigen bioavailability and digestibility are closely
linked and affect the quantity of intact antigen available
for processing and presentation within the immune sys-
tem. Digestibility, assessed in vitro and in vivo, is likely
to vary depending on protein form (purified vs. present
in a matrix). Particular food matrix structures, such as
those in oilseeds, can delay the release of antigen after
ingestion. Likewise, plant cell walls may not be broken
down in the upper digestive tract. Although some matrix
components have been shown to enhance digestion,
most tend to inhibit digestion by restricting access of
proteases to target proteins, outright inhibition of prote-
ases, or competing for digestive enzymes (in the case of
protein-rich matrices). The fatty acid phosphatidylcholine,
a surfactant produced by the stomach and found in milk
and egg yolks, has been shown to delay or inhibit in vitro
digestion of milk allergens. Several studies demonstrate
that pectin and other indigestible polysaccharides can in-
hibit digestion via reduction of pepsin activity, protein–
pectin complex formation and viscosity [19].
Uptake and transport of proteins can be significantly
affected by the presence of a food matrix. For example,
hazelnut extract impedes the transepithelial transport
of milk, hazelnut, and apple allergens in vitro and alters
the kinetics of antigen transit into the blood of fed rats
[20]. These effects are most likely due to the presence
of non-allergen proteins competing for active transport
machinery, given that the hazelnut extract was defatted.
However, matrix lipids may influence antigen traffick-
ing as well. Long-chain fatty acids have been shown to
enhance the uptake of antigen into the plasma and
mesenteric lymph nodes in mice and promote greater
proliferation of antigen-specific T cells. In humans, a
reduction in fat content can profoundly alter the clin-
ical reaction to allergen. In one study, a double-blind
placebo-controlled food challenge of peanut allergic
patients was used to show that an approximately 9%
reduction in fat in the peanut preparation reduced the
amount of peanut required to elicit a reaction [21].
RAST-inhibition curves were not altered by the fat con-
tent of the mixtures, indicating that antibody-binding
properties were unchanged. Thus, it is likely that a higher
fat content served to slow allergen release and absorption.
Lipids may act as a depot adjuvant and sustain the release
of antigen to enhance immune activation as observed in
McClain et al. Clinical and Translational Allergy 2014, 4:11 Page 6 of 9
http://www.ctajournal.com/content/4/1/11rodent models of food allergy where matrix lipids are
found to act as adjuvants for allergic responses to the
allergen on injection (e.g., Brazil nut). Alternatively, the
lipids themselves may be directly immunostimulatory.
Lipids and other components of the food matrix have
the potential to exert immunomodulatory effects. Lipids
in particular have been exploited for their properties as
oral adjuvants (immune stimulating complexes [ISCOMs],
liposomes). Saponins act as adjuvants presumably through
increased antigen uptake, but can also exert effects
when administered at a different site than the antigen.
Plant sterols and lectins can also be immunostimula-
tory. Although not a major allergen, peanut lectin has
mitogenic activity and may therefore enhance systemic
immune reactivity more generally. Additionally, the in-
fluence from food contaminants of microbial or fungal
origin, such as lipopolysaccharides (LPS) or aflatoxin, re-
spectively, may further complicate the immune response
as they may act as adjuvants or modifiers of general im-
mune status. An immunologic phenomenon thought to
limit food allergy is oral tolerance, which can occur when
ingesting soluble antigen leads to hyporesponsiveness to
that specific antigen. Lipids have also been shown to influ-
ence oral tolerance and shape the character of the immune
response to subsequent immunization in animal models.
Furthermore, biophysical features of a matrix such as the
pH can also influence oral tolerance induction, perhaps by
modifying protein structure or solubility or by affecting
digestion prior to or during immune system exposure [22].
The food matrix also affects protein modifications that
may occur during processing. Maillard reactions be-
tween proteins and sugars can induce aggregates, which
increases allergenicity by providing new IgE binding sites
or potentiating more effective crosslinking of IgE mole-
cules. For some allergens, glycation can form new epi-
topes for IgE binding, whereas the glycation of other
allergens can reduce IgE binding. Other considerations
include matrix-related thermostability and altered anti-
genicity due to protein interactions. For example, the
antigenicity of ovomucoid is reduced when combined
with wheat, perhaps due to interactions with wheat gli-
adins [23].
Finally, matrix issues confound measurement of pro-
teins in foods, limiting understanding of exposure. The
matrix in which an allergen is present might alter the re-
activity in patient serum screening experiments, further
complicating the determination of allergenic potential
for the broader population.
Danger signals from allergens: proteolytic action
What makes an allergen an allergen? This question has
been the subject of much speculation and research, and
was carefully considered and discussed at the 2012 sym-
posium. The answer to this question is certainly not asimple characterization applicable to all proteins that
have been identified as allergens. A first prerequisite for
answering the question is to define what an allergen
uniquely possesses. Two properties are part of the defin-
ition: 1) the capacity to trigger the immune system to
start producing specific IgE antibodies, and 2) the cap-
acity to elicit allergic symptoms via an IgE-mediated
mechanism. Many allergens possess both properties, but
some food allergens that are related to pollen allergens
are allergens by virtue of their structural similarity to the
original sensitizer from pollen; the food allergen itself
lacks the capacity to induce IgE antibodies. The sympo-
sium discussion was limited to the capacity of an aller-
gen to induce the IgE antibody induction pathway.
Probably the only prerequisite for the induction of
IgE antibodies that holds true for all proteins is expos-
ure. Without exposure, there can be no response of the
immune system. The dose–response is, however, not a
simple linear relationship, and other ‘danger signals’
favoring induction of IgE and the associated stimulation
of Th2 cells come into play. A ‘danger signal’ that has
attracted much attention is proteolytic activity of proteins.
Most evidence for a role of proteolytic enzymatic activity
in allergenicity comes from studies on cysteine proteases
from house dust mites, i.e., the group 1 allergens from
Dermatophagoides pteronyssinus and Dermatophagoides
farinae, Der p 1 and Der f 1, respectively. Three main
targets of proteolytic activity have been described: the
integrity of the physical barrier of epithelial cells, the
innate immune response orchestrated by structural
cells of this barrier (epithelial cells/keratinocytes), and
the subsequent adaptive immune response.
In a series of elegant experiments reported around the
turn of the century, Robinson and co-workers demon-
strated that tight junctions are disrupted on exposure to
Der p 1, thereby facilitating passage of protein across the
epithelial barrier [24-26]. Disruption of the epithelial
barrier in itself, however, does not definitively make a
cysteine protease an allergen. It simply allows the muco-
sal immune system to be more easily exposed to any
protein from the environment, in addition to the prote-
ases themselves. Whether tight junctions of atopic indi-
viduals are more sensitive to proteolysis is not known.
Around the same time, Stewart and co-workers iden-
tified another consequence of the proteolytic activity of
house dust mite proteases. On exposure to Der p 1
(and the serine protease Der p 9), cultured epithelial
cells started producing the pro-inflammatory cytokines
GM-CSF, IL-6 and IL-8, thus providing a cytokine mi-
lieu favoring induction of inflammatory adaptive im-
mune responses [27]. Further work demonstrated that
protease-activated receptor-2 (PAR-2) but not PAR-1 is
at the basis of the activation of epithelial cells [28]. This
was later confirmed by Jacquet and co-workers [29]. As
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provide a favorable cytokine and chemokine milieu for
induction of IgE and Th2 responses, but it does not
provide an explanation for why one protein under these
conditions induces an IgE response and another does
not.
Additional studies on Der p 1 have shown the poten-
tial for multiple effects of a proteolytically active aller-
gen. In 1995, Shakib and co-workers demonstrated that
Der p 1 cleaves the low-affinity IgE-receptor on B cells
(i.e., CD23), thereby disrupting the negative feedback
loop for IgE production [30,31]. They then showed with
further work that Der p 1 also cleaves CD25, the α-subunit
of the human T-cell IL-2 receptor [32]. The consequence
of this is that proliferation of T cells and production of
IFNγ is inhibited, thus favoring Th2 responses that would
lead to B-cell support and IgE production. In addition to a
direct effect on T cells, it was also demonstrated that
dendritic cells (DCs) are affected by proteolytically ac-
tive Der p 1 [33]. DCs produced less IL-12, and CD40
was cleaved, thus having an impact on activation of T
cells with decreased IFNγ and increased IL-4 produc-
tion. Several other potential pro-allergenic effects have
been described, such a cleavage of DC-SIGN on DCs
[34] and inhibition of indoleamine 2,3-dioxygenase pro-
duction by DCs [35]. Overall, a combination of all of
these effects on the adaptive arm of the immune system
may indeed favor Th2 and IgE responses, although it
should be stressed that these effects do not discriminate
proteolytic enzymes from other proteins present in a
pro-inflammatory milieu.
In summary, there is convincing evidence that cyst-
eine protease activity provides opportunities for those
proteins which are exposed to the mucosal barrier and
immune system and subsequently induce a Th2-type
immune response to act as sensitizing allergens. It does
not, however, explain why some proteins, including
proteases, exposed under these same conditions some-
times do induce a specific IgE response and sometimes
do not induce the full IgE maturation process. The mo-
lecular level processes, in terms of how an enzyme that is
also an allergen may cross the cellular barrier, is important
to understand, regardless of whether the current models
focus on primarily respiratory allergens. Certainly, lessons
learned from allergens such as Der p 1 would have
applicability for testing and characterizing the ability of
any allergen to cross-over epithelial barriers which are
necessary to induce sensitization. The link that is still
missing most likely lies in the way antigen-presenting
cells process proteins and subsequently present pep-
tides to specific T cells. The question, “What makes an
allergen an allergen?”, has not yet been answered, but
proteolytic activity certainly contributes as a co-factor
under certain conditions.Discussion
As noted in existing regulatory safety guidance and nu-
merous publications, food allergy safety relies on an
accumulation of characterization studies rather than a
single test (i.e., a weight-of-evidence approach). En-
dogenous allergens in some food crops have also come
under scrutiny with regard to potential increases due
to the prevalence of GM food crops and, thus, new
technology has been developed to support this aspect
of addressing potential sensitization through exposure
assessments. However, the challenge in identifying
threshold levels or no-adverse-effect levels of most al-
lergens [36], particularly in food crops such as soy-
bean, limits the ability to single out GM foods from
their non-GM counterparts. In fact, emerging research
indicates a high degree of variability in the levels of en-
dogenous allergens in plants and suggests that routine
screening of GM food crops for endogenous allergen
levels does not at this time provide utility for food
safety. A similar form of variability can be observed in
the way human populations respond to allergenic
foods. Global surveys are far from comprehensive, but
tend to show that exposure histories for individuals
differ depending on their diets, an individual’s age at
the time of exposure, and the inherent regional cul-
tures from which they originate. This results in differ-
ences in prevalence for a given food allergen from one
region to another (e.g., North America versus Asia). As
can be surmised, this variability limits simplistic cat-
egorizing of food allergens as having the same level of
risk for individuals in all areas around the world.
Characterizing the biophysical aspects of protein aller-
gens also remains an intense area of study because it is
critical to understand the features that are unique to al-
lergens compared to non-allergens. A long-term object-
ive is to identify the common properties of allergens so
that their potential to cause allergy can be predicted
based on how they become exposed to the immune sys-
tem, are processed by the immune system, remembered
by the immune system, and elicit a clinically significant
allergic response. One of the main factors in under-
standing food allergens is to recognize that they almost
always interact with a complex food matrix before or
during ingestion. These “matrices” are really the sur-
rounding proteins, lipids, and carbohydrates that make
up a plant seed or fruit, for example, and thereby influ-
ence how the human body interacts with allergens. At
the cellular level, the observations of proteolytic effects
on the immune system appear to be direct in some
cases, but there is no direct cause and effect that is so
unique as to place proteolytic allergens separately from al-
lergens or to allow for prediction of a protein’s potential to
sensitize. A biophysical feature such as possessing proteo-
lytic enzyme activity contributes to allergenic potential for
McClain et al. Clinical and Translational Allergy 2014, 4:11 Page 8 of 9
http://www.ctajournal.com/content/4/1/11some proteins under some conditions and will remain an
important consideration in the ongoing characterization of
allergens.
Fully characterizing immune response to protein aller-
gens continues to be a challenge, particularly in terms of
defining the initial sensitizing response and using the
information to predict elicitation and allergy prevalence.
As more foods are distributed globally and as novel pro-
teins are utilized in food crops, ensuring food allergy
safety underlies the need for continued research to
understand how protein allergens are different from
other proteins. As it stands, regulatory guidance for
new and novel foods/food proteins rests on characteriz-
ing the risk of elicitation [37,38]. There is no guidance
that uses a measure of sensitization potential to predict
allergy risk for proteins as a basis for risk determin-
ation, nor are there standardized safety approaches
available. In fact, this has been made clear even through
European regulatory-supported reviews of the science
in this area [39].
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